Mirati Therapeutics Inc

MRTX

Sector
Healthcare

Industry
Biotechnology

Website
mirati.com




Buy / Sell (dollars)

1 Month

13.5% 13.5% Complete (success)
86.5% 86.5% Complete (danger)
$181,154.00
avg. $181,154.00
$1.164M
avg. $1.164M

Buy/Sell Ratio

0.156

Transactions

8

Filers

4

3 Month

1.3% 1.3% Complete (success)
98.7% 98.7% Complete (danger)
$700,412.44
avg. $233,470.81
$53.386M
avg. $17.795M

Buy/Sell Ratio

0.013

Transactions

25

Filers

8

12 Month

18.6% 18.6% Complete (success)
81.4% 81.4% Complete (danger)
$34.815M
avg. $2.901M
$152.255M
avg. $12.688M

Buy/Sell Ratio

0.229

Transactions

82

Filers

18

24 Month

26.8% 26.8% Complete (success)
73.2% 73.2% Complete (danger)
$57.935M
avg. $2.414M
$158.172M
avg. $6.590M

Buy/Sell Ratio

0.366

Transactions

130

Filers

20

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.

No open market CFO buys or sells found.



Filers